BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28587900)

  • 1. Altered reactivity of central amygdala to GABA
    Lamirault C; Yu-Taeger L; Doyère V; Riess O; Nguyen HP; El Massioui N
    Neuropharmacology; 2017 Sep; 123():136-147. PubMed ID: 28587900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behavior and testis morphology in the BACHD rat model.
    Novati A; Yu-Taeger L; Gonzalez Menendez I; Quintanilla Martinez L; Nguyen HP
    PLoS One; 2018; 13(6):e0198338. PubMed ID: 29883458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABAergic control of the activity of the central nucleus of the amygdala in low- and high-anxiety rats.
    Skórzewska A; Lehner M; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Krząścik P; Płaźnik A
    Neuropharmacology; 2015 Dec; 99():566-76. PubMed ID: 26318100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates.
    Manfré G; Novati A; Faccini I; Rossetti AC; Bosch K; Molteni R; Riva MA; Van der Harst JE; Nguyen HP; Homberg JR
    PLoS One; 2018; 13(2):e0192289. PubMed ID: 29415038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
    Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
    Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of gene expression in the striatum of BACHD rats expressing full-length mutant huntingtin and associated abnormalities on molecular and protein levels.
    Yu-Taeger L; Bonin M; Stricker-Shaver J; Riess O; Nguyen HHP
    Neuropharmacology; 2017 May; 117():260-272. PubMed ID: 28153533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
    Pouladi MA; Stanek LM; Xie Y; Franciosi S; Southwell AL; Deng Y; Butland S; Zhang W; Cheng SH; Shihabuddin LS; Hayden MR
    Hum Mol Genet; 2012 May; 21(10):2219-32. PubMed ID: 22328089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(A) Receptors in the Central Nucleus of the Amygdala Are Involved in Pain- and Itch-Related Responses.
    Chen L; Wang W; Tan T; Han H; Dong Z
    J Pain; 2016 Feb; 17(2):181-9. PubMed ID: 26521174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E; Nguyen HP; Löbbecke-Schumacher M; Habbes HW; Wieczorek S; Riess O; Andres KH; Dermietzel R; Von Hörsten S
    J Comp Neurol; 2007 Apr; 501(5):716-30. PubMed ID: 17299753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease.
    Rocher AB; Gubellini P; Merienne N; Boussicault L; Petit F; Gipchtein P; Jan C; Hantraye P; Brouillet E; Bonvento G
    Neurobiol Dis; 2016 Feb; 86():131-9. PubMed ID: 26626081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
    Hult Lundh S; Nilsson N; Soylu R; Kirik D; Petersén Å
    Hum Mol Genet; 2013 Sep; 22(17):3485-97. PubMed ID: 23697793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
    Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
    Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory bulb atrophy and caspase activation observed in the BACHD rat models of Huntington disease.
    Lessard-Beaudoin M; Yu-Taeger L; Laroche M; Singer E; Riess O; Nguyen HHP; Graham RK
    Neurobiol Dis; 2019 May; 125():219-231. PubMed ID: 30738141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
    Yu-Taeger L; Petrasch-Parwez E; Osmand AP; Redensek A; Metzger S; Clemens LE; Park L; Howland D; Calaminus C; Gu X; Pichler B; Yang XW; Riess O; Nguyen HP
    J Neurosci; 2012 Oct; 32(44):15426-38. PubMed ID: 23115180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional Control of Social Behavior by Activity within Basolateral and Central Amygdala of Primates.
    Wellman LL; Forcelli PA; Aguilar BL; Malkova L
    J Neurosci; 2016 Aug; 36(33):8746-56. PubMed ID: 27535919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific ubiquitination of pathogenic huntingtin attenuates its deleterious effects.
    Hakim-Eshed V; Boulos A; Cohen-Rosenzweig C; Yu-Taeger L; Ziv T; Kwon YT; Riess O; Phuc Nguyen HH; Ziv NE; Ciechanover A
    Proc Natl Acad Sci U S A; 2020 Aug; 117(31):18661-18669. PubMed ID: 32675242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered emotional and motivational processing in the transgenic rat model for Huntington's disease.
    Faure A; Höhn S; Von Hörsten S; Delatour B; Raber K; Le Blanc P; Desvignes N; Doyère V; El Massioui N
    Neurobiol Learn Mem; 2011 Jan; 95(1):92-101. PubMed ID: 21111837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a transgenic rodent model for Huntington Disease.
    Adjeroud N; Yagüe S; Yu-Taeger L; Bozon B; Leblanc-Veyrac P; Riess O; Allain P; Nguyen HP; Doyère V; El Massioui N
    Neurobiol Learn Mem; 2015 Nov; 125():249-57. PubMed ID: 26463506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.